These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 36669597)
1. The phytoestrogenic potential of flavonoid glycosides from Selaginella moellendorffii via ERα-dependent signaling pathway. Yuan S; Li Z; Huang W; Chen K; Li J J Ethnopharmacol; 2023 May; 308():116174. PubMed ID: 36669597 [TBL] [Abstract][Full Text] [Related]
2. Activation of G protein-coupled receptor 30 by thiodiphenol promotes proliferation of estrogen receptor α-positive breast cancer cells. Lei B; Peng W; Xu G; Wu M; Wen Y; Xu J; Yu Z; Wang Y Chemosphere; 2017 Feb; 169():204-211. PubMed ID: 27880919 [TBL] [Abstract][Full Text] [Related]
3. Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERα signaling. Zhou L; Poon CC; Wong KY; Cao S; Dong X; Zhang Y; Wong MS Phytomedicine; 2021 Feb; 82():153413. PubMed ID: 33339654 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway. Hou X; Zhao M; Wang T; Zhang G Oncol Rep; 2014 Mar; 31(3):1175-82. PubMed ID: 24366110 [TBL] [Abstract][Full Text] [Related]
5. CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells. Nguyen Hoang AT; Hoe KL; Lee SJ PLoS One; 2021; 16(4):e0246264. PubMed ID: 33861751 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Pozo-Guisado E; Lorenzo-Benayas MJ; Fernández-Salguero PM Int J Cancer; 2004 Mar; 109(2):167-73. PubMed ID: 14750165 [TBL] [Abstract][Full Text] [Related]
8. Siwu decoction exerts a phytoestrogenic osteoprotective effect on postmenopausal osteoporosis via the estrogen receptor/phosphatidylinositol 3-kinase/serine/threonine protein kinase pathway. Yang J; Cong N; Shi D; Chen S; Zhang Z; Zhao P J Ethnopharmacol; 2024 Oct; 332():118366. PubMed ID: 38763371 [TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588 [TBL] [Abstract][Full Text] [Related]
10. Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression. Bowers LW; Cavazos DA; Maximo IX; Brenner AJ; Hursting SD; deGraffenried LA Breast Cancer Res; 2013; 15(4):R59. PubMed ID: 23880059 [TBL] [Abstract][Full Text] [Related]
11. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Sun H; Yin M; Qian W; Yin H Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951 [TBL] [Abstract][Full Text] [Related]
12. Jeong YH; Kim TI; Oh YC; Ma JY Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232743 [TBL] [Abstract][Full Text] [Related]
13. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer. Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422 [TBL] [Abstract][Full Text] [Related]
14. Crude terpene glycoside component from Radix paeoniae rubra protects against isoproterenol-induced myocardial ischemic injury via activation of the PI3K/AKT/mTOR signaling pathway. Ke Z; Wang G; Yang L; Qiu H; Wu H; Du M; Chen J; Song J; Jia X; Feng L J Ethnopharmacol; 2017 Jul; 206():160-169. PubMed ID: 28549860 [TBL] [Abstract][Full Text] [Related]
15. microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity. Martin EC; Rhodes LV; Elliott S; Krebs AE; Nephew KP; Flemington EK; Collins-Burow BM; Burow ME Mol Cancer; 2014 Oct; 13():229. PubMed ID: 25283550 [TBL] [Abstract][Full Text] [Related]
16. Bisphenol AF exerts estrogenic activity in MCF-7 cells through activation of Erk and PI3K/Akt signals via GPER signaling pathway. Lei B; Sun S; Zhang X; Feng C; Xu J; Wen Y; Huang Y; Wu M; Yu Y Chemosphere; 2019 Apr; 220():362-370. PubMed ID: 30590302 [TBL] [Abstract][Full Text] [Related]
17. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847 [TBL] [Abstract][Full Text] [Related]
18. Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Kazi AA; Koos RD Endocrinology; 2007 May; 148(5):2363-74. PubMed ID: 17272396 [TBL] [Abstract][Full Text] [Related]
19. Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression. Hall BA; Kim TY; Skor MN; Conzen SD Breast Cancer Res Treat; 2012 Sep; 135(2):469-79. PubMed ID: 22842983 [TBL] [Abstract][Full Text] [Related]
20. Estrogen facilitates both phosphatidylinositol 3-kinase/Akt and ERK1/2 mitogen-activated protein kinase membrane signaling required for long-term neuropeptide Y transcriptional regulation in clonal, immortalized neurons. Titolo D; Mayer CM; Dhillon SS; Cai F; Belsham DD J Neurosci; 2008 Jun; 28(25):6473-82. PubMed ID: 18562618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]